Not surprisingly, ovarian (92.2%), pancreatic (86.7%), breast (84.4%), and prostate (83.3%) cancers exhibited the highest rates of biallelic BRCA1/2 alterations, indicating a strong link to biallelic gene loss. This evidence concerns the gene BRCA1 and cancer.